Michael C Wu

10PUBLICATIONS
57CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Microbial geneticsAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Apr 21, 2026
Cellular neighborhoods govern antitumor T-cell infiltration following anti-CTLA-4 in melanoma with primary resistance to anti-PD-1.

|Jan 29, 2026
Neoadjuvant PD-1 blockade in surgically resectable desmoplastic melanoma: cohort A of the phase 2 SWOG S1512 trial.

Kari L Kendra, Shay L Bellasea, Zeynep Eroglu

|Aug 26, 2025
Publisher Correction: Anti-PD-1 therapy in unresectable desmoplastic melanoma: the phase 2 SWOG S1512 trial.

Kari L Kendra, Shay L Bellasea, Zeynep Eroglu

|Aug 14, 2025
Anti-PD-1 therapy in unresectable desmoplastic melanoma: the phase 2 SWOG S1512 trial.

Kari L Kendra, Shay L Bellasea, Zeynep Eroglu

|Oct 18, 2024
Reverse Selection Designs for Accommodating Multiple Control Arms.

Sarah Samorodnitsky, Megan Othus, Michael LeBlanc

|Sep 23, 2021
Testing microbiome association using integrated quantile regression models.

Tianying Wang, Wodan Ling, Anna M Plantinga

Pageof 2

Frequent Collaborators

4 joint publications

Alexandra P Ikeguchi

4 joint publications

Egmidio Medina

4 joint publications

Antoni Ribas

4 joint publications

Katie M Campbell